You are here

Rapid Viral Pandemic Suppression With Molecular Affinity Development

Award Information
Agency: Department of Defense
Branch: Defense Logistics Agency
Contract: SP4701-21-P-0022
Agency Tracking Number: L202-011-0088
Amount: $99,905.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: DLA202-011
Solicitation Number: 20.2
Solicitation Year: 2020
Award Year: 2021
Award Start Date (Proposal Award Date): 2020-11-19
Award End Date (Contract End Date): 2021-05-18
Small Business Information
P.O. Box 616 19 Loveton Circle
Sparks, MD 21152-1111
United States
DUNS: 808275890
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Yingyun Liu
 (410) 903-7412
Business Contact
 Diane Murray
Phone: (936) 588-6901
Research Institution

This SBIR Phase I project will develop a platform and protocol to rapidly identify and prepare materials and methods for the suppression of a viral pandemic after the virus has been identified and sequenced. The project will focus on the currently ongoing COVID-19 pandemic, but the platform can apply to future viral pandemics. With this platform, pandemics can be suppressed with at least two of the four venues: diagnostics, surveillance, vaccines, and therapeutics. The platform intends to use a combination of tools from the fields of bioinformatics and molecular biology to identify and prepare target molecules with high affinity binding potential. The prepared molecules can then be used in disease diagnosis, surveillance, vaccine formulation, and/or therapeutics discovery. With such applications implemented, the platform can significantly enhance the response time and effectiveness of pandemic suppression measures. As a result, people and military personnel will maintain health and operational readiness and avoid loss of life, suffering, and economic hardship.  

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government